NEWSROOM

Biotech

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Oct 31, 2025

Key Takeaways Caveat Emptor Removal Marks New Growth PhaseProtext Mobility, Inc. (OTC: TXTM) announced a renewed strategic focus following the removal of its Caveat Emptor designation, signaling restored market confidence. Leadership Alignment with ShareholdersPresident and Chairman Dylon Du Plooy confirmed that he has personally purchased more than 200 million TXTM shares in the open market since 2024, while the CEO’s preferred shares will remain unconverted, eliminating dilution risk. No...

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

Oct 27, 2025

POMPANO BEACH, FL, October 27, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM) (the “Company”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that the Audit Committee of its Board of Directors has approved the appointment of KPMG LLP (“KPMG”) as the Company's independent registered public accounting firm, and it...

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Oct 27, 2025

Protext Mobility to launch IR Presentation & MicrositeTXTM is rolling out a modern investor hub to elevate transparency and engagement, aligning communications with top-tier governance standards. Next-gen investor access in one placeThe hub centralizes real-time financials, filings, interactive charts, live press releases, investor webcasts, and email alerts—creating a single command center for shareholders. Governance first, clear timelineProtext is voluntarily EDGARizing disclosures and...

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Oct 27, 2025

Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies Halberd Demonstrates NeuroSense AI FeasibilityHalberd Corporation successfully validated its NeuroSense AI system in a live demonstration, showcasing advanced multi-modal behavioral analysis technology designed to revolutionize traumatic brain injury (TBI) research and neurological diagnostics. AI-Powered Insights into Brain and Behavioral FunctionThe NeuroSense AI...

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement

Oct 17, 2025

NEW YORK, Oct. 17, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Protext Mobility, Inc. (OTC: TXTM), an emerging leader in botanical-based biotechnology, today announced its strategic initiative to redesign its corporate website and develop a dedicated Investor Relations (IR) Suite, as part of the company’s commitment to transparency, regulatory compliance, and proactive investor communication. This planned digital transformation reflects Protext’s mission to...

Digital Utilities Ventures Completes Acquisition and Name Change

Digital Utilities Ventures Completes Acquisition and Name Change

Oct 9, 2025

Planned uplist to OTCQB Venture Exchange, if approved will follow completion of audit and previously announced reverse split Mankato, Minn., October 9, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions, has received notice that the processing of its corporate action by FINRA has been completed. As a result, the Company finalizes its acquisition of Lifestyle Dock Company,...

Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water

Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water

Oct 8, 2025

New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, NJ, October 8, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to medical and commercial markets, today announced the launch of its new filter designed to reduce Total PFAS, or per- and polyfluoroalkyl substances (PFAS), in potable water. This product expands Nephros’ portfolio to address a...

California Governor Newsom Signs AB30 Approving 15% Ethanol Blend that Increases Ethanol Market by more than 600 million Gallons Per Year

California Governor Newsom Signs AB30 Approving 15% Ethanol Blend that Increases Ethanol Market by more than 600 million Gallons Per Year

Oct 3, 2025

CUPERTINO, Calif., October 3, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and biofuels company, announced today that California Governor Gavin Newsom signed Assembly Bill 30 (AB30), which immediately allows 15% ethanol blending in gasoline and expands the potential California market for ethanol by 50% by increasing from an E10 to E15 blend. According to a study by UC Berkeley/Naval Academy, a 15% ethanol...

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program

Oct 2, 2025

Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., October 2, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, and the Florida Panthers, announced today that...

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Sep 25, 2025

LAS VEGAS, Sept. 25, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced that its MyCardia AT device has been issued a Medical Device License (MDL) by Health Canada and is now approved for import into Canada, effective immediately. The device, rebranded as the CardioHolter AT, will be...

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Sep 4, 2025

LAS VEGAS, Sept. 04, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new distribution agreement with Noventis Medical, granting the Company five-year exclusive rights to distribute CBSC’s products across Costa Rica, Panama, Colombia, and Argentina. Under the...

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

Aug 21, 2025

POMPANO BEACH, FL, August 21, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, discloses an insider purchase of common stock from Jason Matuszewski, Chairman and Chief Executive Officer of BioStem Technologies. Mr. Matuszewski purchased a total of 15,500 shares on August 19, 2025, totaling approximately $100,000. The purchases were...

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

Jul 31, 2025

SOUTH ORANGE, N.J., July 31, 2025 - PRISM MediaWire - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025, after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon...

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Jul 30, 2025

NEW YORK, NY and SANTA BARBARA, CA, July 30, 2025 - PRISM MediaWire - Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March 31, 2041. This patent underpins one of the Company’s key pipeline assets, a modified stilbenoid, and importantly provides the Company with exclusivity to particular compounds per se, formulations containing a number of drug candidates, and...

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

Jul 9, 2025

Ten-Year Legacy Brand Joins THCT Portfolio, Expanding National Craft Cannabis Footprint and Female-Founded Leadership Medford, OR, July 8, 2025 - PRISM MediaWire - THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the legal and regulated cannabis industry, is proud to announce the acquisition of all issued and outstanding membership interests of STHoldings Group LLC, the parent company of iconic Eugene, Oregon cannabis brand SugarTop Buddery, in an all-share...

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers

Jun 23, 2025

Head-to-head study comparing BioREtain®- processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis expected in Q4 2025 POMPANO BEACH, Fla., June 23, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today...

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

Jun 17, 2025

Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies POMPANO BEACH, Fla., June 17, 2025 - PRISM MediaWire - Ernst & Young LLP (EY US) announced that Jason Matuszewski, CEO and Chairman of the Board of BioStem Technologies (OTC: BSEM), was named an Entrepreneur Of The Year 2025 Florida Award winner. Entrepreneur Of The Year is the preeminent competitive awards program for entrepreneurs and leaders of high-growth companies. For 40 years, EY US...

Easy Environmental Solutions Begins Manufacturing EasyFEN™ Units for Africa Following Initial Down Payment

Easy Environmental Solutions Begins Manufacturing EasyFEN™ Units for Africa Following Initial Down Payment

Jun 10, 2025

Easy Environmental Solutions Inc. announces that the client sent the initial deposit and agreed to the $3.4 million modular EasyFEN order for Africa. EasyFEN units produce organic Terreplenish liquid microbial fertilizer, transforming waste into a feed that supports over 16 million people in Africa. Terreplenish liquid microbial fertilizer enhances soil health, increases crop yields, and reduces irrigation needs by up to 20%. PR Audio: Welcome, MN, June 10, 2025 - PRISM MediaWire - Digital...

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Jun 10, 2025

UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., June 10,...

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Jun 4, 2025

Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral Lichen Planus, a condition with no approved treatments PITTSBURGH, June 4, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it has re-signed its manufacturing collaboration agreement with Cook...

BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 29, 2025

POMPANO BEACH, Fla., May 29, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that the company will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, which is taking place in Miami. Jason Matuszewski, the Company’s CEO, will participate in a fireside chat and will be available for...

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates

Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates

May 28, 2025

Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease JACKSON CENTER, Pa., May 28, 2025 - PRISM MediaWire - Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney...

BioStem Announces Notice of Allowance for Three New U.S. Patent Applications

BioStem Announces Notice of Allowance for Three New U.S. Patent Applications

May 28, 2025

Expanding patent portfolio reinforces the Company’s commitment to wound care innovation, with 55 issued patents and 52 pending applications POMPANO BEACH, Fla., May 28, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance...

Catheter Precision, Inc. Receives CE Mark for LockeT

Catheter Precision, Inc. Receives CE Mark for LockeT

May 27, 2025

Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 - PRISM MediaWire - Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device. Receipt of the CE Mark indicates compliance with European Union (EU)...

BioStem Announces Notice of Allowance for Three New U.S. Patent Applications

Ernst & Young (EY) US Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award finalist

May 22, 2025

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future POMPANO BEACH, Fla., May 22, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM) (the “Company” or “BioStem”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that Jason Matuszewski, CEO of BioStem is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur...

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 20, 2025

USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologies CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 20, 2025 - PRISM MediaWire - Aclarion, Inc.,...

PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators

PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators

May 12, 2025

NEW YORK, May 12, 2025 - PRISM MediaWire - In recognition of Mental Health Awareness Month, PRISM MarketView reaffirms its commitment to highlighting the critical importance of mental health and the ongoing efforts to improve mental well-being across the nation. Established in 1949 by Mental Health America, Mental Health Awareness Month serves to educate the public about mental illnesses, promote mental wellness, and reduce the stigma associated with mental health conditions. This year's...

Easy Environmental Solutions Begins Manufacturing EasyFEN™ Units for Africa Following Initial Down Payment

Digital Utilities Ventures CEO Mark Gaalswyk Meets with QFFD in Qatar

May 6, 2025

Easy Environmental Solutions, Inc. Enters Strategic Talks with QFFD and African Governments to Accelerate a New Era of Regenerative Agriculture and Clean Water Infrastructure Strategic Partnership with QFFD to Transform Agriculture and Water Sustainability in Africa: Easy Environmental Solutions, Inc. (OTC: DUTV) is actively engaging with the Qatar Fund for Development (QFFD) and multiple African governments to launch scalable regenerative agriculture and clean water initiatives. This...

BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting

May 1, 2025

Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem’s advanced allograft portfolio POMPANO BEACH, Fla., May 1, 2025 - PRiSM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced its agenda for the...

Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues

Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues

Apr 29, 2025

Digital Utilities Ventures (OTC: DUTV) is evolving into Easy Environmental Solutions, Inc., to better reflect its focus on environmental sustainability. The company will continue to advance regenerative agriculture, clean water access, and a net carbon-neutral future through subsidiaries like Easy Energy Systems Technologies and Feed Earth Now. Under the transition from Digital Utilities Ventures (DUTV) to Easy Environmental Solutions, Inc., the company remains committed to developing...